WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 8801 Infant (under 12 months) mortality rate: 362
GDP / capita (US$): 2'4941 Child (under 5 years) mortality rate: 432

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 14'865  14'606  14'365  14'144  13'941  12'223  9'057  6'699 
Births 386  383  379  373  367  336  386  315 
Surviving infants 370  366  362  356  349  310  353  243 
Pop. less than 5 years 1'669  1'629  1'592  1'575  1'580  1'486  1'731  875 
Pop. less than 15 years 4'629  4'583  4'573  4'587  4'641  4'985  4'003  2'739 
Female 15-49 years 4'085  4'031  3'965  3'900  3'820  3'094  2'186  1'752 

Number of reported case

(Click for retrospective incidence data for Cambodia)
Diphtheria 179  1'559 
Japanese encephalitis 55  45  41  193  372 
Measles 15  722  1'156  4'779  4'211  12'237  2'473  32'240 
Mumps 17 
Pertussis 54  372  513  1'212  2'068  1'690  86'334 
Polio* 63  591 
Rubella 185  1'096  85  528  4'211 
Rubella (CRS) 32 
Tetanus (neonatal) 15  19  27  34  295 
Tetanus (total) 15  27  324  295  219  2'089 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Cambodia)
Vaccine year result method % card seen                                                
BCG 2009  94  DHS   77.4  99  99*  94  99*  98  81  51 
DTP1 2009  93  DHS   77.4  97  96  93  100  95  78 
DTP3 2009  85  DHS   77.4  95  94  92  94  91  59  38 
HepB_BD          65  68  57  55  46 
HepB3 2009  85  DHS   77.4  95  94  92  91 
Hib3 2009  85  DHS   77.4  95  94  92 
JapEnc         
MCV 2009  82  DHS   77.4  93  93  93  92  89  65  34 
MCV2          82 
PCV1         
PCV3         
Pol3 2009  85  DHS   77.4  95  94  92  95  91  62  38 
Rota1         
Rota_last         
Rubella1         
TT2plus 2004  54  DHS   66.7  73  64  57  62  57  40 
PAB         
VAD1          99*  95  98  88  40 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Cambodia)
BCG 99  97  94  96  98  81  52 
DTP1 97  96  93  99  95  78  63 
DTP3 95  94  92  94  91  59  38 
HepB3 95  94  92  92  91 
Hib3 95  94  92 
MCV 93  93  93  92  89  65  34 
PAB 91  91  91  91  87  58  11 
PCV3
Pol3 95  94  92  95  91  62  38 
Rota_last

Number of districts in the country 79  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 57
From 80 to 89% 28
From 50 to 79% 13
Less than 50% 3
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB birth; Yes
JapEnc 10 months; No
Measles 9, 18 months; Yes
OPV 6, 10, 14 weeks; Yes
TT 1st contact pregnancy; +1, +6 month; +1, +1 year; Yes
VitaminA 6-59 months (x2); Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2008-2015  2008-2015  2008 to 2015  2008-2015  2008-2015  2008-2015  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 78  77  77      77  76 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  No         

System performance

Total number of districts in country number 79  77  77  77  77  77  76 
Nº districts with DTP3 coverage >=80% number 67  63  66  68  62  39  29 
% of districts with DTP3 coverage >=80% From 0 to 100% 85  82  86  88  81  51  38 
Nº districts with measles (MCV1) coverage >=95% number 37  28  25  19  17     
% of districts with MCV1 coverage >=95% From 0 to 100% 47  36  32  25  22     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  No  No 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND No  No  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 25  23  40  22  41  17 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No No  No  No  No  No  No  No 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.